|
US5997873A
(en)
*
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
WO1997006821A1
(en)
*
|
1995-08-18 |
1997-02-27 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6773707B1
(en)
*
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
*
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6719974B1
(en)
*
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
IN183280B
(https=)
|
1996-09-20 |
1999-10-30 |
Univ New Mexico |
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
BE1011033A6
(fr)
*
|
1997-03-05 |
1999-04-06 |
Univ Bruxelles |
Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
|
|
US6709672B2
(en)
*
|
1997-03-05 |
2004-03-23 |
Biotech Tools S.A. |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
|
|
KR20060111731A
(ko)
*
|
1997-08-05 |
2006-10-27 |
스트레스젠 바이오테크놀러지스 코포레이션 |
사람 유두종 바이러스 항원과 스트레스 단백질을 포함하는융합 단백질을 포함하는 조성물에 의해 유도된 사람 유두종바이러스 항원에 대한 면역 반응
|
|
EP1027070A4
(en)
*
|
1997-10-31 |
2004-08-18 |
Sloan Kettering Institutefor C |
CONJUGATES FROM HEAT SHOCK PROTEIN-BINDING PEPTIDES
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
JP4768122B2
(ja)
*
|
1998-02-20 |
2011-09-07 |
ユニバーシティー オブ マイアミ |
改変型熱ショックタンパク質−抗原性ペプチド複合体
|
|
US20030236209A1
(en)
*
|
1998-03-18 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
CA2342832A1
(en)
*
|
1998-09-04 |
2000-03-16 |
Powderject Research Limited |
Immunodiagnostics using particle delivery methods
|
|
US20020142974A1
(en)
*
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
|
CA2378097A1
(en)
|
1999-07-08 |
2001-01-18 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
WO2001023421A2
(en)
*
|
1999-09-30 |
2001-04-05 |
Corixa Corporation |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US7378096B2
(en)
*
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US8128922B2
(en)
*
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
AU1582801A
(en)
*
|
1999-11-05 |
2001-06-06 |
Board Of Regents Of The University Of Nebraska, The |
Methods and compositions for protection against bovine herpesvirus
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20010034042A1
(en)
*
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
US7297330B2
(en)
*
|
2000-02-04 |
2007-11-20 |
Thomas Jefferson University |
Low dose haptenized tumor cell and tumor cell extract immunotherapy
|
|
DE10019967A1
(de)
*
|
2000-04-20 |
2001-10-25 |
Fenning Biomed Gmbh Dr |
Antikörper gegen natives gp96, deren Herstellung und Verwendung
|
|
US7449557B2
(en)
|
2000-06-02 |
2008-11-11 |
University Of Connecticut Health Center |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
US7179462B2
(en)
|
2000-06-02 |
2007-02-20 |
University Of Connecticut Health Center |
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
US7186515B1
(en)
|
2000-06-02 |
2007-03-06 |
University Of Connecticut Health Center |
Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
DK1296711T3
(da)
*
|
2000-06-26 |
2006-08-28 |
Stressgen Biotechnologies Corp |
HPV-E7 til behandling af humant papillomavirus
|
|
EP1363938B1
(en)
*
|
2000-08-03 |
2013-12-11 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
CN1107681C
(zh)
*
|
2000-08-11 |
2003-05-07 |
中国科学院微生物研究所 |
乙肝病毒抗原多肽与热休克蛋白的复合物及其应用
|
|
CA2422867A1
(en)
*
|
2000-09-15 |
2002-04-25 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
*
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US6921534B2
(en)
|
2001-02-05 |
2005-07-26 |
Stressgen Biotechnologies Corporation |
Hepatitis B virus treatment
|
|
US20030096000A1
(en)
*
|
2001-05-31 |
2003-05-22 |
Solis Rosa Maria |
Encapsulation of nanosuspensions in liposomes and microspheres
|
|
US7186693B2
(en)
|
2001-08-16 |
2007-03-06 |
Kimberly - Clark Worldwide, Inc. |
Metalloproteinase inhibitors for wound healing
|
|
US7094754B2
(en)
|
2001-08-16 |
2006-08-22 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
US7071164B2
(en)
|
2001-08-16 |
2006-07-04 |
Kimberly-Clark Worldwide, Inc. |
Anti-cancer and wound healing compounds
|
|
US6906036B2
(en)
|
2001-08-16 |
2005-06-14 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
HK1079705A1
(zh)
*
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
US20030211971A1
(en)
*
|
2001-09-17 |
2003-11-13 |
Srivastava Pramod K. |
Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
|
|
EP1551957A4
(en)
|
2001-10-01 |
2007-01-24 |
Univ Duke |
ISOLATED POLYPEPTIDE OF THE GRP94 LIGANDEN BINDING DOMAIN AND NUCLEIC ACID, CRYSTALLINE FORM THEREOF, CODING THEREOF, AND SCRAPPING METHOD WHERE IT IS USED
|
|
US20030194409A1
(en)
*
|
2002-01-17 |
2003-10-16 |
Rothman James E. |
Conjugate heat shock protein-binding peptides
|
|
CA2477417A1
(en)
*
|
2002-02-28 |
2003-09-04 |
Antigenics Inc. |
Methods and products based on oligomerization of stress proteins
|
|
WO2003090686A2
(en)
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
WO2003092624A2
(en)
*
|
2002-05-02 |
2003-11-13 |
University Of Connecticut Health Center |
Use of heat shock proteins to enhance efficacy of antibody therapeutics
|
|
EP1714981A3
(en)
*
|
2002-10-02 |
2006-12-20 |
F.Hoffmann-La Roche Ag |
Method for the identification of antigenic peptides
|
|
CA2501577A1
(en)
*
|
2002-10-07 |
2004-04-22 |
Antigenics, Inc. |
Heat shock protein binding fragments of cd91, and uses thereof
|
|
US20060148064A1
(en)
*
|
2002-10-25 |
2006-07-06 |
Srivastava Pramod K |
Apparatus and method for immunotherapy of a cancer through controlled cell lysis
|
|
US7550256B2
(en)
*
|
2002-12-13 |
2009-06-23 |
Aurelium Biopharma, Inc. |
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7413851B2
(en)
|
2002-12-13 |
2008-08-19 |
Aurelium Biopharma, Inc. |
Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7670604B2
(en)
|
2002-12-13 |
2010-03-02 |
Aurelium Biopharma, Inc. |
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7148194B2
(en)
|
2002-12-30 |
2006-12-12 |
Kimberly-Clark Worldwide, Inc. |
Method to increase fibronectin
|
|
AU2003300676A1
(en)
*
|
2003-01-03 |
2004-07-29 |
Aurelium Biopharma Inc. |
Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
CA2512161A1
(en)
*
|
2003-01-28 |
2004-08-12 |
Shanghai Sunway Biotech Co., Ltd |
Hyperthermia oncolysis co-therapy
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
RU2324493C2
(ru)
*
|
2003-02-20 |
2008-05-20 |
Юниверсити Оф Коннектикут Хелт Сентер |
Способ применения композиций, содержащих белки теплового шока или альфа-2-макроглобулин, для лечения рака и инфекционных болезней
|
|
US7638122B2
(en)
*
|
2003-03-07 |
2009-12-29 |
University Of South Florida |
Stat3 antagonists and their use as vaccines against cancer
|
|
WO2004080819A2
(en)
*
|
2003-03-14 |
2004-09-23 |
Aurelium Biopharma Inc. |
Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7309491B2
(en)
*
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
EP1644048B1
(en)
*
|
2003-05-05 |
2015-04-29 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
US20060029610A1
(en)
*
|
2003-05-12 |
2006-02-09 |
Yair Argon |
GRP94-based compositions and methods of use thereof
|
|
CA2525385A1
(en)
*
|
2003-05-12 |
2004-11-25 |
The Children's Hospital Of Philadelphia |
Grp94-based compositions and methods of use thereof
|
|
US7189700B2
(en)
|
2003-06-20 |
2007-03-13 |
Kimberly-Clark Worldwide, Inc. |
Anti-chrondrosarcoma compounds
|
|
JPWO2006025526A1
(ja)
*
|
2004-09-03 |
2008-05-08 |
株式会社医学生物学研究所 |
Ｃｔｌ誘導能を獲得した樹状細胞の製造方法
|
|
JPWO2006025525A1
(ja)
*
|
2004-09-03 |
2008-05-08 |
株式会社医学生物学研究所 |
樹状細胞において抗原提示されやすいタンパク質の選択方法
|
|
WO2006073970A2
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2006081323A2
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
RU2287339C1
(ru)
*
|
2005-04-29 |
2006-11-20 |
Автономная некоммерческая организация "Институт Молекулярной Диагностики" (АНО ИнМоДи) |
Способ получения препарата, содержащего комплекс белков теплового шока 70,90,96, ассоциированных с антигенными пептидами
|
|
US20070167422A1
(en)
*
|
2006-01-18 |
2007-07-19 |
Yu Kwok S |
Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
|
|
US20100330105A1
(en)
*
|
2006-08-22 |
2010-12-30 |
John Hopkins University |
Anticancer Combination Therapies
|
|
WO2008063996A2
(en)
*
|
2006-11-13 |
2008-05-29 |
Functional Genetics, Inc. |
Therapeutic targeting of escort proteins
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
|
KR20110017356A
(ko)
|
2008-03-20 |
2011-02-21 |
유니버시티 오브 마이애미 |
열충격 단백질 ｇｐ96 백신접종 및 이를 사용하는 방법
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
US7932018B2
(en)
*
|
2008-05-06 |
2011-04-26 |
Az Electronic Materials Usa Corp. |
Antireflective coating composition
|
|
AU2009262670B2
(en)
|
2008-06-26 |
2013-06-20 |
Zevra Denmark A/S |
Use of Hsp70 as a regulator of enzymatic activity
|
|
GB0816242D0
(en)
*
|
2008-09-05 |
2008-10-15 |
Immunobiology Ltd |
Method of purifying protien complexes
|
|
US9332973B2
(en)
|
2008-10-01 |
2016-05-10 |
Covidien Lp |
Needle biopsy device with exchangeable needle and integrated needle protection
|
|
US8968210B2
(en)
|
2008-10-01 |
2015-03-03 |
Covidien LLP |
Device for needle biopsy with integrated needle protection
|
|
US9186128B2
(en)
|
2008-10-01 |
2015-11-17 |
Covidien Lp |
Needle biopsy device
|
|
US9782565B2
(en)
|
2008-10-01 |
2017-10-10 |
Covidien Lp |
Endoscopic ultrasound-guided biliary access system
|
|
US11298113B2
(en)
|
2008-10-01 |
2022-04-12 |
Covidien Lp |
Device for needle biopsy with integrated needle protection
|
|
CN102223894A
(zh)
*
|
2008-11-21 |
2011-10-19 |
迈阿密大学 |
用于产生粘膜和系统免疫的hiv/siv疫苗
|
|
GB0910591D0
(en)
|
2009-06-19 |
2009-07-29 |
Immunobiology Ltd |
Method for the purification of protein complexes
|
|
CA2817773A1
(en)
|
2010-11-30 |
2012-06-07 |
Orphazyme Aps |
Methods for increasing intracellular activity of hsp70
|
|
FR3005649B1
(fr)
|
2013-05-15 |
2023-03-31 |
Urodelia |
Poudre d'hydroxyapatite et son procede de production, composition a base de cette poudre et son procede de preparation et kit comprenant cette poudre
|
|
SG10201912986PA
(en)
|
2014-05-28 |
2020-02-27 |
Agenus Inc |
Anti-gitr antibodies and methods of use thereof
|
|
AU2015317447B2
(en)
|
2014-09-15 |
2021-02-25 |
Zevra Denmark A/S |
Arimoclomol formulation
|
|
BR112017016681A2
(pt)
|
2015-02-06 |
2018-04-10 |
Heat Biologics Inc |
vetor de coexpressão de vacina e moléculas coestimulatórias
|
|
SG10201912485PA
(en)
|
2015-05-13 |
2020-02-27 |
Agenus Inc |
Vaccines for treatment and prevention of cancer
|
|
MA44594B1
(fr)
|
2015-05-29 |
2020-09-30 |
Memorial Sloan Kettering Cancer Center |
Anticorps anti-ctla-4 et méthodes d'utilisation de ceux-ci
|
|
CN114605548A
(zh)
|
2015-09-01 |
2022-06-10 |
艾吉纳斯公司 |
抗-pd-1抗体及其使用方法
|
|
IL299072A
(en)
|
2015-12-02 |
2023-02-01 |
Memorial Sloan Kettering Cancer Center |
Antibodies and methods for using them
|
|
US10898563B2
(en)
*
|
2016-02-29 |
2021-01-26 |
The Curators Of The University Of Missouri |
Cancer immune-based therapy
|
|
US10898476B2
(en)
|
2016-04-13 |
2021-01-26 |
Orphazyme A/S |
Heat shock proteins and cholesterol homeostasis
|
|
DK3782624T3
(da)
|
2016-04-29 |
2025-12-15 |
Zevra Denmark As |
Arimoclomol til behandling af glucocerebrosidase-associerede lidelser
|
|
TWI781934B
(zh)
|
2016-05-27 |
2022-11-01 |
美商艾吉納斯公司 |
抗-tim-3抗體及其使用方法
|
|
SG10201912663YA
(en)
|
2016-10-11 |
2020-03-30 |
Agenus Inc |
Anti-lag-3 antibodies and methods of use thereof
|
|
US11666649B2
(en)
|
2016-10-11 |
2023-06-06 |
University Of Miami |
Vectors and vaccine cells for immunity against Zika virus
|
|
WO2018106862A1
(en)
|
2016-12-07 |
2018-06-14 |
Agenus Inc. |
Anti-ctla-4 antibodies and methods of use thereof
|
|
JP7106538B2
(ja)
|
2016-12-07 |
2022-07-26 |
アジェナス インコーポレイテッド |
抗体およびその使用方法
|
|
CN110198954A
(zh)
|
2017-01-13 |
2019-09-03 |
艾吉纳斯公司 |
与ny-eso-1结合的t细胞受体和其使用方法
|
|
CA3058938A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
JP7297672B2
(ja)
|
2017-04-13 |
2023-06-26 |
アジェナス インコーポレイテッド |
抗ｃｄ１３７抗体およびその使用方法
|
|
RS64576B1
(sr)
|
2017-05-01 |
2023-10-31 |
Agenus Inc |
Anti-tigit antitela i postupci njihove primene
|
|
KR20200052327A
(ko)
|
2017-09-04 |
2020-05-14 |
아게누스 인코포레이티드 |
혼합 계통 백혈병 (mll)-특이적 포스포펩타이드에 결합하는 t 세포 수용체 및 그것의 사용 방법
|
|
FR3078887B1
(fr)
|
2018-03-14 |
2020-12-18 |
Urodelia |
Vaccins autologues contre le cancer
|
|
MA52363A
(fr)
|
2018-04-26 |
2021-03-03 |
Agenus Inc |
Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
|
|
TW202122420A
(zh)
|
2019-08-30 |
2021-06-16 |
美商艾吉納斯公司 |
抗ｃｄ９６抗體及其使用方法
|
|
WO2022070052A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Alma Bio Therapeutics |
Nucleic acid therapy for differential modulation of host microflora
|
|
KR20230128462A
(ko)
|
2020-11-19 |
2023-09-05 |
제브라 덴마크 에이/에스 |
아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정
|
|
FR3165777A1
(fr)
|
2024-08-27 |
2026-03-06 |
Hastim |
Vaccin autologue contre le cancer enrichi en HSP110
|